The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Vectoring In — Viral Vector Video Series
Video
When preparing to ramp up late stage manufacturing for commercialization, understanding key critical to quality parameters will help prepare your therapy for regulatory submission.
In this ‘Vectoring In’ video series, our experts will talk you through how they guide clients to prepare for regulatory submission with a focus on quality attributes.
Part 1: Avoiding CMC Delays in Cell & Gene Therapies
Discusses the impact of attention to early phase development and partnering with an experienced CDMO to prepare for regulatory submissions.
Interested in learning more? Access videos 2-4 in this series, featuring the following topics:
- What Regulators are Looking for in Cell & Gene Therapy Submissions
- Bypassing Late-Phase Viral Vector Process Speed Bumps
- Accelerating Late Phase Development